CATALYST PHARMACEUTICALS, INC. - Common Stock (CPRX)

CUSIP: 14888U101

Q4 2013 13F Holders as of 31 Dec 2013

Security identity
Shares outstanding
123,180,519
Holder snapshot
Share change
+20,970
Reported price per share
$1.95
Number of holders
31
Value change
+$41,000
Number of buys
2

Security key

14888U101

Report period

Q4 2013

Institutions

31

Top holders

10

Ownership snapshot

Top reported holders of CPRX - CATALYST PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder
13D/G signal
Evidence rows
0
Latest as of
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

13F holder rows

Institutional holders as of Q4 2013

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
31
Shares
9,288,823
Rows available
31
Investor Option Weight % Change % Reported value * Price Shares Share Change Activity Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q4 2013 vs Q3 2013 Across Filers

Q3 2013 holders
0
Q4 2013 holders
31
Holder diff
31
Investor Q3 2013 Shares Q4 2013 Shares Share Diff Share Chg % Q3 2013 value Q4 2013 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .